Last reviewed · How we verify
NCT06118671
The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community
NA trial testing personalized lifestyle intervention by AI in Diabetes in 460 participants. Status unknown.
7 November 2024
Quick facts
| Lead sponsor | Chongqing Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 460 |
| Start date | 7 November 2023 |
| Primary completion | 7 November 2024 |
| Estimated completion | 7 November 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- personalized lifestyle intervention by AI
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
Chongqing Medical University
Who can join
Adults 18 to 80, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about the application and effectiveness evaluation of artificial intelligence (AI) in lifestyle management of diabetic patients in community.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China.
Wang Z, Xia X, Lu W, Ye Y, et al · · 2025 · cited 1× · PMID 39910261 · DOI 10.1038/s41746-025-01477-6
Verify or expand the search:
- PubMed search for NCT06118671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Chongqing Medical University trials
Trials by the same sponsor.
- NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
- NCT07503509 — Physiological Study of High PEEP in Noninvasive Ventilation · NA · recruiting
- NCT06272032 — Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis · EARLY_PHASE1 · unknown
- NCT05974566 — Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction · unknown
- NCT05974904 — Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06118671 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chongqing Medical University
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06118671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing